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Objectives—This studys examined the relationship between substance use disorder (SUD) and
intimate partner violence screening (IPV) and management practices in the emergency department
(ED).
Methods—This was a retrospective cohort study of adult ED patients presenting to an urban,
tertiary care teaching hospital over a 4-month period. An automated electronic data abstraction
process identified consecutive patients and retrieved visit characteristics, including results of three
violence screening questions, demographic data, triage acuity, time of visit, and ICD-9 diagnosis
codes. Data on management were collected using a standardized abstraction tool by two reviewers
masked to the study question. Multivariate logistic regression was used to determine predictors of
screening and management.
Results—In 10,071 visits, 6,563 violence screens were completed. IPV screening was
documented in 33.5% of patients with alcohol-related diagnoses (95% CI = 27.7% to 39.3%, χ2 =
116.78, p < 0.001) and 53.3% of patients with drug-related diagnoses (95% CI = 44.3% to 62.3%,
χ2 = 7.69, p = 0.006), compared to 66.1% of patients without these diagnoses (95% CI = 65.2% to
67.1%). In the multivariate analysis, alcohol (OR 0.30, 95% CI = 0.22 to 0.40) and drug use (OR
0.56, 95% CI = 0.38 to 0.83) were associated with decreased odds of screening. Of completed
screens, 429 (6.5%) were positive, but violence was addressed further in only 55.7% of patients.
Substance abuse did not appear to affect the odds of having positive screens addressed further by
providers (OR 1.96, 95% CI = 0.39 to 10.14).
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Conclusions—This study found an association between SUD and decreased odds of IPV
screening. Failure to screen for IPV in the setting of substance use may represent a missed
opportunity to address a critical health issue, and be a barrier to successful intervention.
MeSH Keywords
Domestic violence; Substance-related disorders

INTRODUCTION
Intimate partner violence (IPV) may lead to substance use disorders (SUD), increase
substance use severity, prevent patients from seeking substance use treatments, and
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exacerbate psychiatric and medical illnesses in those with SUD.1–4 Screening for IPV in
patients with drug or alcohol problems may help providers recognize and address a major
barrier to the success of substance abuse interventions and referrals.5,6
To the best of our knowledge, no prior studies have examined IPV screening among
emergency department (ED) patients with SUD. Our primary objective was to investigate
whether substance use is associated with failure to perform IPV screening in the ED. A
secondary objective was to examine whether SUD is associated with failure to address
violence further among patients who screen positive for IPV. Such information could help
direct violence screening and treatment protocols to ensure inclusion, rather than systematic
exclusion, of populations at risk for poor health outcomes.

METHODS
Study Design
This was a retrospective cohort chart study of visits by adult patients (18 years or older) who
presented to the ED between June 2008 and October 2008. The research protocol, including
waiver of informed consent, was approved by the study site’s institutional review board.
Study Setting and Population
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The study was conducted at an urban academic tertiary care center with an emergency
medicine residency training program and an annual volume of approximately 40,000
patients. An electronic medical record system, Epic Hyperspace (Epic Systems Corporation,
Verona, WI), is used for all clinical documentation. While IPV screening is generally
conducted in triage, it may be completed at any time. A single screening form is visible to
nurses throughout the patient encounter, and is used for data entry regardless of when the
screen is actually completed. The site has dedicated ED social workers 24 hours a day, 7
days a week. Social workers are contacted when IPV is identified, and facilitate patient
referral to appropriate resources.
We calculated a sample size of 10,000 ED visits based on a goal of detecting a 20%
difference in screening between patients with and without substance abuse diagnoses, using
α of 0.05 and 80% power. Using estimates for visits meeting exclusion criteria (Emergency
Severity Index level 1 acuity, elopement, or “against medical advice” discharges), we
sampled 10,564 charts. After applying exclusion criteria, the final sample included 10,071
visits.
Study Protocol
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Patient demographics and visit characteristics were obtained through automated abstraction
of information from the electronic medical record. Chart review was performed by two
trained research assistants (RAs) who were masked to the associations under investigation.
A standardized data abstraction tool was developed for the study using Microsoft Access
(Microsoft Inc., Redmond, WA) and piloted using 50 screen-positive medical charts. RAs
were provided with a guide containing the chart review protocol and definitions of variables.
Data collection was monitored by the primary investigator. The study team met periodically
to review guidelines and discuss and resolve any problems that arose in the data collection
process. To gauge interrater reliability, 10% of the charts were randomly selected for review
by both RAs.
Measurements
The primary outcome of interest was completed IPV screening. Our ED uses a threequestion screen for IPV: “Do you have a restraining order against anyone?”, “Have you been
Acad Emerg Med. Author manuscript; available in PMC 2011 August 1.
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physically assaulted in the last year?”, and “Have you had forced sexual activity in the last
year?” If any of the three questions was answered “Yes,” this was considered a “positive”
screen; if all were “No,” this was considered a “negative” screen. If all three answers were
left blank, screening was considered missed.
The screening questions at our institution are broad and inclusive. A positive screen is not
considered diagnostic, but leads to a screen prompt for the triage nurse to notify a provider –
whether primary nurse, physician, nurse practitioner, or social worker – to clarify the nature
of the violence and determine if intervention is needed. Thus, a secondary outcome of
interest was whether positive screens were subsequently addressed by providers. This was
determined by manual review of charts with positive screens. IPV was considered to have
been addressed if there was any mention of IPV within the provider notes, including
clarification of the nature of the positive screen, confirmation of ongoing IPV, services
offered for partner abuse, or a discharge diagnosis of abuse.
Substance use was defined by International Classifications of Disease, 9th revision (ICD-9)
diagnoses for dependent and non-dependent alcohol and illicit drug use, and acute
psychiatric and medical illness related to alcohol or drug use (codes 291-291.99,
303-303.99, 305.0-305.03, 535.3-535.31, 571.1, 790.3, 292.0-292.9, 304-304.93,
305.2-305.93).
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Data Analysis
We used a priori hypotheses to identify the demographic and clinical factors likely to
influence screening. Key variables were entered into a multivariate logistic regression model
to determine independent predictors of completed screening. To assess interrater reliability,
we calculated a κ-statistic for data collected by both RAs.
Statistical significance was defined as a probability of a type I error of less than 5% (twotailed). Results are presented as odds ratios (ORs; screened vs. not screened) with 95%
confidence intervals (CIs). All analyses were performed by using Stata 10.0 (Stata Corp,
College Station, TX).

RESULTS
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Data from 10,071 ED visits were reviewed. Substance use was identified in 369 patients
(3.7%): 257 (2.6%) were alcohol-related and 122 (1.2%) were drug-related. Overall, 65.2%
of ED patients received screening for IPV, of whom 6.5% screened positive for IPV.
Answers to all three questions were documented in 98.2% of the completed screens.
Frequency and proportions of completed screening, based on patient characteristics, are
shown in Table 1 (column A). IPV screening was documented in 33.5% of patients with
alcohol-related diagnoses (95% CI = 27.7% to 39.3%, χ2 = 116.78, p < 0.001) and 53.3% of
patients with drug-related diagnoses (95% CI = 44.3% to 62.3%, χ2 = 7.69, p = 0.006),
versus 66.1% of patients without these diagnoses (95% CI = 65.2% to 67.1%). Table 1
(column B) shows the results of the multivariate analysis for the study’s primary outcome.
Patients with substance-related diagnoses had decreased odds of being screened for IPV
(alcohol diagnoses, OR 0.30, 95% CI = 0.22 to 0.40; drug diagnoses, OR 0.56, 95% CI =
0.38 to 0.83).
There were positive violence screens in 429 visits. These charts were reviewed manually to
determine if the positive screens resulted in any documentation by providers suggesting that
they had addressed the screen. Violence was addressed further in 55.7% of patients with
positive screens. The RAs had 88% agreement (κ = 0.75) in determining whether violence
had been addressed. Results of the multivariate analysis for this outcome are shown in Table
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1 (column C). Among those who screened positive, SUD did not appear to affect the odds of
having IPV addressed by ED providers, although of note, only eight (2%) had substance use
diagnoses.

DISCUSSION
We describe an association between substance use and failure to perform screening for IPV.
The odds of having the screen addressed by a provider did not differ between those with and
without substance use diagnoses, although this finding may be an artifact of the small
number of patients with substance use and a positive screen.
Many major medical societies, including the American College of Emergency Physicians,
support routine inquiry about IPV in all patients. Yet in 2004, the United States Preventive
Services Task Force stated that it could not advocate for routine screening for IPV, given
insufficient data supporting any benefit of this practice.7 A recent Canadian study conducted
in a variety of healthcare settings again failed to demonstrate a benefit to screening the
general population for IPV.8
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Could systematic neglect of IPV screening in patients most likely to test positive explain, in
part, this apparent lack of benefit? While characteristics associated with IPV are myriad,
case finding for certain groups of patients has intuitive appeal. The high morbidity and
hospital costs associated with SUD have led to great efforts to develop effective means of
intervening in substance abuse in the acute care setting.9 Consideration of significant and
common barriers to care – such as IPV – may be one way to optimize the success of such
interventions, and improve the health and safety of these patients.
Our study highlights another potential reason screening has not been shown to benefit
patients: screening does not guarantee appropriate management. Of patients with positive
violence screens, only 55.7% had evidence that the screen led to any action by ED
providers. Although this proportion is higher than that in the Canadian trial of IPV
screening,8 it is still unacceptably low.

LIMITATIONS
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This preliminary study was conducted at a single, relatively low-volume ED with full-time
social work services. A larger, multicenter study is needed to affirm the generalizability of
these findings. Further, our determination of screening relies on clinician documentation. It
is possible nurses screened patients but failed to document these actions, although there is no
reason failure to document should have occurred differentially between patients with and
without substance use.
Claims-based diagnosis is less accurate for SUD than the structured measurement tools used
in other study types and likely underestimates substance use.10 Our findings may reflect
screening practices in a subset of patients with more severe and overt drug and alcohol use.
Regardless, our study identifies a high-risk population in need of improved violence
screening.

CONCLUSIONS
We found an association between substance use and failure to complete screening for
intimate partner violence in the ED. This finding is concerning, and suggests a missed
opportunity to identify and address an important barrier to successful treatment of substance
abuse problems. Further investigation is needed to explore this potential systematic bias, and
consider ways to improve how violence is addressed among our most vulnerable patients.
Acad Emerg Med. Author manuscript; available in PMC 2011 August 1.
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Table 1

Patient Characteristics and Violence Screening.
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Total (N)

A) Screened
N (%)

10,071

6,563 (65.2)

42.7 (±17.0)

Female
Male

Total, No.
Age, years mean (±SD)

B) OR, Screened
(95% CI)

C) OR, Addressed
(95% CI)

40.9 (±15.7)

0.94 (0.92–0.95)†

1.01 (0.99–1.03)†

5,098

3,562 (69.9)

Reference

Reference

4,970

3,001 (60.4)

1.37 (1.25–1.50)

0.97 (0.64–1.47)

7,882

5,260 (66.7)

Reference

Reference

666

445 (66.8)

0.87 (0.73–1.05)

0.57 (0.26–1.23)

745

427 (57.3)

0.99 (0.81–1.23)

1.01 (0.44–2.36)

413

238 (42.4)

0.84 (0.67–1.05)

1.62 (0.56–4.69)

9,435

6,283 (66.6)

Reference

Reference

636

280 (44.0)

0.33 (0.26–0.41)

0.78 (0.31–1.97)

3,681

2,405 (65.3)

Reference

Reference

Sex, No.

Race/Ethnicity
White
Black or African
American
Hispanic
Other
Primary language

NIH-PA Author Manuscript

English
Non-English
Insurance status
Commercial or other
insured

1,856

1,077 (58.0)

0.96 (0.83–1.11)

0.97 (0.52–1.85)

Medicare

1,622

1,117 (68.9)

1.04 (0.90–1.20)

1.89 (1.02–3.50)

Medicaid

2,912

1,964 (67.5)

1.08 (0.97–1.23)

1.69 (0.99–2.91)

Uninsured or unknown
Triage acuity*
2

1,704

645 (37.9)

Reference

Reference

3

6,106

4,273 (70.0)

3.58 (3.19–4.03)

0.95 (0.54–1.68)

4 or 5

1,990

1,624 (81.6)

6.14 (5.24–7.20)

1.36 (0.69–2.67)

Day (7:00a–2:59p)

4,161

2,873 (69.1)

Reference

Reference

Evening (3:00p–10:59p)

4,372

2,728 (62.4)

0.82 (0.74–0.91)

1.51 (0.96– 2.37)

Night (11:00p–6:59a)

1,538

962 (62.6)

0.93 (0.81–1.07)

0.84 (0.45–1.57)

Mental health diagnoses^

443

263 (59.4)

0.91 (0.73–1.13)

0.91 (0.33–2.45)

Presenting shift
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Substance use diagnoses^

1.96 (0.39–

Alcohol

257

86 (33.5)

0.30 (0.22–0.40)

Drug

122

65 (53.3)

0.56 (0.38–0.83)

10.14)††

A) Proportion screened for violence; B) Odds ratios for completed violence screening; C) Odds ratios for having positive screens addressed further
*

Patients categorized as level 1 with the Emergency Severity Index were excluded

^
Mental health and substance use were dichotomous variables representing “present” or “absent.” The reference value for specific diagnosis
variables was 0, or “absent.”
†

Reflects OR for every 5-year increase in age

Acad Emerg Med. Author manuscript; available in PMC 2011 August 1.

Choo et al.

Page 7

††

Alcohol and drug use diagnoses were combined in this analysis, given the small numbers of either diagnosis among patients screening positive
for violence.
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